前收市價 | 0.2500 |
開市 | 0.2500 |
買盤 | 0.0000 |
賣出價 | 0.2500 |
拍板 | 18.00 |
到期日 | 2024-09-20 |
今日波幅 | 0.2500 - 0.2500 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 45 |
Short-squeeze moves can be ferocious and are perfect for investors seeking quick trading gains. With the possibility of a rate cut-induced rally, I am bullish on some short-squeeze stocks for the next few quarters. I am a long-term investor. However, I don’t shy away from taking trading positions in 5% to 10% of my fund allocation towards equities. When there are some clear short-squeeze opportunities, it makes sense to make 50% or 100% gains and invest the profits in long term bets. Of course,
Recently, the cannabis market received the best hoped-for news. The Drug Enforcement Administration (DEA) announced it is moving forward with plans to reschedule marijuana from a Schedule I to a Schedule III controlled substance. While this excited many investors, the cannabis market is still a ways away from full federal legalization. While the DEA’s announcement has led to a surge in cannabis stocks, companies facing pre-existing challenges are unlikely to see immediate improvements. In partic
Investors should not get overly excited about President Biden’s decision to reclassify marijuana. The potential move toward becoming a less dangerous schedule 3 drug is lengthy and will not result in cannabis becoming federally legal. That has important implications in relation to access to financing for cannabis firms among other things. This has led to investors considering if there are any cannabis stocks to sell as the road to Federal legalization is still long. Nothing has changed following